Neural stem cell (NSC) transplantation induces recovery in animal models of central nervous system (CNS) diseases. Although the replacement of lost endogenous cells was originally proposed as the primary healing mechanism of NSC grafts, it is now clear that transplanted NSCs operate via multiple mechanisms, including the horizontal exchange of therapeutic cargoes to host cells via extracellular vesicles (EVs).
Introduction
Extracellular vesicles (EVs) are a heterogeneous population of secreted membrane vesicles with distinct biogenesis, biophysical properties and functions, which are virtually common to virtually all cells and life forms [27] . Despite their proven biological potential, the characterization and classification of this heterogeneous population of membrane vesicles has thus far been challenging.
A working basis for a consensus classification system of EVs is divided into three major subtypes based on biogenic, morphological, and biochemical properties: exosomes, microvesicles (MVs), and apoptotic bodies [64] . Exosomes are small vesicles, ranging 30 -150 nm in diameter, generated from the inward budding of intracellular multi-vesicular bodies and released after the subsequent fusion with the plasma membrane [65] . MVs are membranous vesicles generated by clathrinmediated shedding of the plasma membrane and released into the extracellular space, with a diameter ranging 50 -1,000 nm [65] . Apoptotic bodies are generated through apoptotic fragmentation and blebbing with a resultant size range of 1,000 -5,000 nm [18] .
Neural stem cells (NSCs) are classically defined as a heterogeneous population of selfrenewing, multipotent stem cells of the developing and adult central nervous system (CNS), which reside within specialized microenvironments and drive neurogenesis and gliogenesis [17, 44] . Data from our lab and peers have shown that in addition to the (expected) cell replacement, NSCs are strikingly able to engage in multiple mechanisms of action in the diseased CNS [3, 17] , including the horizontal exchange of therapeutic cargoes to host cells via EVs [51] . However, the function and contribution of these cargoes to the broad therapeutic effects of NSCs is not fully understood.
We have recently focused on defining the nature and function of intercellular signalling mediated by EVs from NSCs [9, 26] . Using a series of computational analyses and high resolution imaging techniques, we have demonstrated that EVs deliver functional interferon gamma/interferon gamma receptor 1 (IFN-g/Ifngr1) complexes to target cells [9] . We also discovered that EVs are endowed with intrinsic metabolic activities and harbour selective L-asparaginase activity catalysed by the enzyme Asparaginase-like protein 1 [26] . functional analyses unveiled structurally and functionally-intact, free and EV-embedded, mitochondria. We next studied the trafficking of these EV-embedded mitochondria (Mito-EVs) into target cells and found that Mito-EVs were efficiently incorporated by both somatic cells and professional phagocytes in vitro. Specifically, Mito-EVs rescue mitochondrial function in mtDNA deficient L929 Rho 0 cells, as well as integrate into the host mitochondrial network of inflammatory macrophages (Mφ), thus modifying their metabolic profile and pro-inflammatory gene expression.
When EVs and NSCs were used to treat mice with myelin oligodendrocyte glycoprotein (MOG)induced experimental autoimmune encephalomyelitis (EAE), we found that exogenous NSCs actively transferred mitochondria to mononuclear phagocytes and induced a significant amelioration of clinical deficits.
Our data suggest that horizontal transfer of functional mitochondrial via EVs is a mechanism of signalling used by NSCs to modulate the physiology and metabolism of target cells, opening a possible new avenue for the development of acellular therapies aimed at correcting mitochondrial dysfunction in the CNS. controlled at 0.01% for 'high' confidence PSMs and 0.05% for 'medium' confidence PSMs.
Normalisation was automated and based on total s/n in each channel. Proteins/peptides satisfying at least a 'medium' FDR confidence were taken forth for further analysis. To compare protein abundances in particles, exosomes and NSCs, moderated t-tests were performed using the limma R/Bioconductor software package, with false discovery rate (FDR)-adjusted p values (q values) calculated according to the Benjamini-Hochberg method. To analyse subcellular localisations of proteins identified or enriched in particles and/or exosomes, Gene Ontology Cellular Component (GOCC) terms were imported using the Perseus software platform. Further data manipulation and general statistical analysis were conducted using Excel and XLSTAT. The proteomic data described in this study have been deposited to the ProteomeXchange consortium via the PRIDE partner repository (accessible at http://proteomecentral.proteomexchange.org). A dataset identifier will be provided prior to publication, and an access key made available to reviewers on request.
Western blotting
Whole cell pellets were solubilised in 100 µl of RIPA buffer (10 mM Tris HCl pH 7. 2 precast NuPAGE Bis/Tris gels (1.5 mm thickness). Before loading, samples were heated at 95°C for 5 min, then loaded onto the gels and then run at 120V in MOPS running buffer. Samples were then transferred on polyvinylidene fluoride membranes (0.45 µm pore size, Immobilon) filter paper sandwich using XCell II Blot Module and NuPAGE transfer buffer (Invitrogen).
For immunoblot analysis, the membranes were blocked with 5% non-fat milk in 0.1% PBS-Tween 20 (Sigma) for 1 hr at room temperature and then incubated with the following primary antibodies (diluted in 5% non-fat milk in 0.1% PBS-Tween 20) for 18 hrs at 4°C: Mouse monoclonal Total OXPHOS rodent WB cocktail (Abcam ab110413, 1:1,000); mouse monoclonal Total OXPHOS bluenative WB cocktail (Abcam ab110412, 1:1,000); rat monoclonal anti-CD9 (BD Pharmingen 553758, 1:1000); mouse monoclonal anti-Pdcd6ip (AIP-1/Alix) (BD transduction lab 611620, 1:500); goat polyclonal anti-TSG101 (Santa Cruz sc-6037, 1:500); rabbit monoclonal TOMM20 (Santa Cruz sc-11415,1:1000); rabbit polyclonal ant-H3 (Abcam ab1791,1:10,000), mouse monoclonal anti-ß-actin (Sigma, A1978 1:10000), mouse monocolonal anti-Gm130/Golga2 (BD Transduction Laboratories 610823, 1:1,000). Molecular weight marker: SeeBlue Plus2 (Invitrogen).
After primary antibody incubation, membranes were washed 3 times for 10 minutes with 0.1% 
PBS

Transmission Electron Microscopy (TEM) and Cryo-Transmission Electron Microscopy (Cryo-TEM)
For TEM analysis EVs were derived from NSCs, as described above. Supernatant was carefully removed and the pellets were fixed with PFA 4%-PBS1X for 10 min at room temperature, and then in fresh portion of PFA 4%-PBS1X for overnight at 4°C. After removal of the fixative, and a short rinse with PBS1X, the pellets were post-fixed in 1% OsO 4 For immuno-gold labelling and cryo-transmission electron microscopy (cryo-TEM) analysis, 10nm gold nanoparticles (NP) were conjugated with anti-TOMM20 monoclonal antibody (Abcam ab232589) following the procedures previously described [2] . Re-suspended EV pellets were labelled for 1 h with anti-TOMM20-gold-NP at 1-3 × 10 15 gold-NP/L. Immuno-gold labelled EV samples were processed for cryo-TEM according to standard procedures. A 4 μL aliquot was deposited on an EM grid coated with a perforated carbon film. After draining the excess liquid with a filter paper, grids were plunge-frozen into liquid ethane cooled by liquid nitrogen using a Leica EMCPC cryo-chamber. For cryo-TEM observation, grids were mounted onto a Gatan 626 cryoholder and transferred to a Tecnai F20 microscope (ThermoFisher, USA) operated at 200 kV. Images were recorded with an Eagle 2k CCD camera (FEI, USA).
Blue Native Polyacrylamide Gel Electrophoresis (BN-PAGE)
Extractions of proteins in native conditions from EVs, isolated mitochondria and NSCs were performed as previously described [47] .
EVs native protein extraction: EVs derived from 36x10 6 NSCs were incubated on ice for 10 min in hypotonic buffer solution (EDTA-Na 1 mM, Tris HCl 6 mM, pH 8) with added Protease Inhibitor Cocktail 1X. Next, EVs were homogenized with a pestle and isotonic conditions were restored by adding sorbitol 1 M (final concentration 0.32 M), EDTA 0.5 M (final concentration 10 mM) and Tris-HCl 1 M (final concentration 10 mM). The extract was then centrifuged at 10,000 x g for 10 min, washed with PBS 1X and centrifuged again at 10,000 x g for 5 min. Pellet was resuspended with Medium A supplemented with bovine serum albumin (BSA) and centrifuged 10,000 x g for 10 min.
This pellet was then resuspended in 50 µl of Medium A and 5 µl were taken for BCA protein quantification. Ultimately, the extracts were centrifuged again at 10,000 x g for 10 min and resuspended at a protein concentration of 5 mg/ml in solubilisation buffer (1.5 M aminocaproic acid, 50 mM Bis-Tris/HCl pH= 7.0). For the solubilisation, 1.6 mg of n-dodecyl-β-D-maltoside (DDM) per mg of protein was added. Samples were incubated on ice for 5 minutes, then centrifuged at 20,000
x g for 30 min at 4°C. Supernatants were collected and a same volume of sample buffer (750 mM aminocaproic acid, 50 mM Bis-Tris/HCl, pH 7.0, 0.5 mM EDTA, and 5% Serva Blue G) was added.
The samples were stored at -80°C until it was time to perform BN-PAGE.
NSCs native proteins extractions: pellet from 3x10 6 cells was resuspended in 200 µl of PBS 1X.
200 µl of cold digitonin solution (8 mg/mL dissolved in PBS), was added to the sample and kept in ice. After 10 min of incubation, digitonin was diluted by adding 1 ml of cold PBS and cells were centrifuged at 10,000 x g for 5 minutes at 4°C. This step was repeated twice. Cells pellets were then resuspended in 100 µl of PBS and 5 µl was taken for protein quantification. Next, PBS was removed by centrifuging at 10,000 x g for 5 min and cell pellet was solubilised as described for EV samples.
Isolated mitochondria native protein extraction: mitochondrial pellet was resuspended in 100 µl of PBS and 5 µl was taken for protein quantification. Next, Medium A was removed by centrifuging at 10,000 x g for 5 min, and the pellet containing the isolated mitochondria, was solubilized and processed as previously described for EVs and NSCs.
A total of 50 µg of protein for each of the samples was loaded into a pre-cast NativePAGE 3-12%
Bis-Tris gel (Invitrogen). For the run, 1x NativePAGE Running Buffer plus 1x NativePAGE Cathode Buffer Additive (Invitrogen) was added to the cathode and 1x NativePAGE Running Buffer was added to the anode. Half-way through the run the cathode buffer was substituted for 1x NativePAGE Running Buffer plus 0.1x NativePAGE Cathode Buffer Additive and run until the front reached the end of the gel.
In-gel mitochondrial complexes activity
After the electrophoresis gels were incubated with the following buffers containing the substrates and electron acceptors necessary for the colorimetric reactions to take place [70] . and finally data were expressed as JC1 ratio Red-over-Green fluorescence (JC1-R/G).
High resolution respirometry (HRR -Oroboros oxygraph respiration assay)
Mitochondrial respiration in permeabilized NSCs and hypotonic-shock treated EVs was analysed by high resolution respirometry (HRR) (Oroboros oxygraph, Innsbruck, Austria). HRR analysis was performed based on previously published methods [22, 42] . Briefly, a 2 ml oxygraph (Oxygraph-2k;
Oroboros) chamber was washed with 70% ethanol, rinsed 3 times with distilled water, then filled with the respiration medium (Medium A plus 1 mM adenosine diphosphate (ADP), 2 mM potassium phosphate and 1 mg/ml fatty acid free BSA) to be used in each of the assays. 20x10 6 NSCs were resuspended in 2 ml of Medium A (20 mM HEPES (adjusted to pH 7.1 with NaOH or KOH), 250 mM sucrose, 10 mM MgCl 2 ). For permeabilization, the cell suspension was incubated with 5 µl of 1% digitonin solution for 1 min at room temperature on a tube oscillator. Digitonin was then diluted with 5 mL of Medium A and removed by centrifugation at 1000xg for 3 min. Finally, the pellet was resuspended in 2.1 ml of respiration medium and added into the chamber.
EVs from 36 x10 6 were isolated and subjected to hypo-osmotic shock as described above. Upon removal of homogenization Medium A through centrifugation at 10,000 x g, for 10 min, hypotonicshock treated vesicles were equilibrated in MAITE medium (25 mM sucrose, 75 mM sorbitol, 100 mM KCl, 0.05 mM EDTA, 5 mM MgCl 2 , 10 mM Tris-HCl, 10 mM phosphate, pH 7.4). The suspension was centrifuged at 10,000 x g for 10 min, resuspended in 100 µl of MAITE buffer, then diluted up to 2.1 mL of MAITE plus 1 mg/ml fatty acid free BSA.
Once samples were loaded in the chambers, a polyvinylidene fluoride stopper was inserted to generate a closed system with a final volume of 2 ml. Oxygen concentration was recorded at 0.5 Hz and converted from voltage to oxygen concentration using a two-point calibration. Respiration rates 
Lentiviral particles generation and NSCs transduction
To label NSCs, cells were transduced in vitro using a third-generation lentiviral carrier (pRRLsinPPT-hCMV) coding for the enhanced farnesylated (f)GFP, which targets the fluorescent protein to the inner plasma membrane of transduced cells [16] . To label mitochondria of NSCs, cells were transduced in vitro using a third generation lentiviral (pLL3.7) carrier coding for the enhanced MitoDsRed expression (i.e. a fusion protein that encodes the leader sequence of cytochrome oxidase IV linked to the florescent protein DsRed), which targets the fluorescent protein to the mitochondrial matrix. The functional stability of these cells (in the absence or in the presence of the lentiviral transcript) has been confirmed with clonal and population studies [54] . Briefly, neurospheres were harvested, dissociated to a single cell suspension and seeded at high density [1.5x10 6 in a T75 cm 2 flask (Sigma-Aldrich)] in 5 ml fresh medium. After 12 hrs, 3x10 6 T.U./ml of lentiviral vectors were added and 6 hrs later additional 5 ml of fresh medium were added. 72 hrs after viral transduction, cells were harvested, re-seeded at normal concentration and transgene expression was measured by FACS analysis.
L929-Rho 0 experiments
Mouse Fibroblasts L929-Rho 0 were a kind gift by Prof Jose' Antonio Enriquez (CNIC, Madrid Spain). They were grown as adherent cells in fibroblasts medium [DMEM, high glucose, GlutaMAX™ Supplement, pyruvate (Gibco), 10% fetal bovine serum (FBS), 1% pen/strep (Invitrogen) and uridine (Sigma) 50 µg/ml] until they reached confluency (80-90%). The day of passage, cells were washed with PBS (Gibco). Trypsin (0.05% in DMEM) was added at 37°C and inactivated after for 3 min with fibroblast medium (2:1). Cells were collected and spun at 200 x g for 5 min, and then re-seeded 1:5 in T175 flasks for normal expansion.
For our experiments, L929-Rho 0 cells were collected, centrifuged at 200 x g for 5 min, then seeded on 13 mm cover slips (5x10 3 forward, 5′-TTCCAATTAGTAGATTCTGAATAAACCCAGAAGAGAGTAAT-3′ and mt-ND3 reverse 5′-CGTCTACCATTCTCAATAAAATTT-3′. PCR amplification protocol was described above. All PCR products were first evaluated on 2% agarose gels (as described above) and then purified using the QIAquick GelExtraction Kit (www.qiagen.com). Sanger sequencing of these products was performed with reverse primers by Source Bioscience (www.sourcebioscience.com). Obtained sequences were visualized and analysed with 4peaks (https://nucleobytes.com/4peaks/index.html).
Bone marrow derived macrophages (Mφ) culture
Bone marrow derived macrophages (Mφ) were obtained from the bone marrow of C57BL/6 mice, as previously described [49] . Briefly, 9-10 weeks old C57BL/6 female mice were anesthetized with 2% isoflurane and killed by cervical dislocation. Bone marrow was flushed from femurs and tibiae and bone marrow progenitor cells were cultured for 6 days on Petri dishes (Thermo Scientific) in Mφ medium [(DMEM high glucose, Gibco), 10% FBS, 1% pen/strep (Invitrogen) and 10% of conditioned media from L-929 fibroblast cells containing macrophage colony-stimulating factor (mCSF)]. 
Analysis of endocytosis/phagocytosis
Fluorescent-activated cell sorting (FACS) analysis
Exogenous mitochondria uptake was assessed in LPS-stimulated Mφ at 6hr, following Mito- 
Quantification of Mito-EVs included in mitochondria, lysosomes and peroxisomes
To analyse the integration of Mito-EVs, Mφ were plated in an 8-well chamber slide (Nunc Lab-
Tek II Chamber Slide System, ThermoFisher scientific, Massachusetts, USA) (50,000 cells/well), and left to rest overnight.
For mitochondria staining, Mφ were exposed to 100 nM of MitoTracker Green FM (M-7514, ThermoFisher scientific, Massachusetts, USA) for 10 min and then washed with media. Mφ were then stimulated with 50 ng/ml LPS (Enzo life sciences) and after 1 hr, EVs extracted from Mito-DsRed + NSCs were resuspended in Mφ medium and added in the same well (ratios: 1 Mφ : EVs collected from 30 Mito-DsRed + NSCs). At 6 hrs of incubation, live images and videos (0.15 frames per second, fps) were acquired using a Dragonfly Spinning Disk imaging system (Andor Technologies Ltd.) composed by a Nikon Ti-E microscope, Nikon 60x TIRF ApoPlan and a Ixon EMCCD camera. The videos were processed (8 fps) and the images analysed using the Imaris v.9.1.2 software (Bitplane AG, Zurich, Switzerland). The 3D surface and spots were created for the mitochondrial network and the EVs, respectively. The distance between the surface and spots were calculated using two different thresholds (0 µm to count for including EVs into the network and 0.5
µm for attaching). The analysis of n≥ 10 cells per condition was done blinded (n= 3).
For lysosomes and peroxisomes staining, Mφ were treated as above with LPS and EVs extracted from Mito-DsRed + NSCs. At 6 hrs of incubation cells were washed with PBS three times and fixed with 4% PFA. The anti-LAMP1 (Abcam ab24170,1:500) or PMP70 (Sigma, SAB420018, 1:500) primary antibodies were used to stain for lysosomes or peroxisomes. Images were acquired using a Dragonfly Spinning Disk system as described above but using a Zyla sCMOS camera instead.
MitoDsRed + EVs co-localisation analysis was performed in n≥ 10 cells per condition using Imaris software and X coefficient was calculated (n= 3).
Quantification of mitochondrial network morphology
Mφ were plated on coverslips (Microscope Cover Glasses, Glaswarenfabrik Karl Hecht GmbH, Sondheim, Germany) at 50,000 cells/well and the next day stimulated with 50 ng/ml LPS (Enzo life sciences). After 1 hr of LPS stimulation, Mφ were treated with or without EVs extracted from Mito-DsRed + NSCs for another 6 hrs, washed with PBS three times and fixed with 4% PFA. Cells were then permeabilised with 0.1% Triton X-100, blocked in 5% goat serum and stained with an anti-TOMM20 antibody (rabbit, Santa Cruz, Dallas, USA, 1:300). Representative images were acquired as described above for the integration analysis. The mitochondrial network analysis was performed in a blind way scoring each cell (n = 3) as fused, intermediated or fragmented in respect of their mitochondrial network (average of n = 140 cells/experiment).
Extracellular flux (XF) assays
A XF24e Extracellular Flux Analyser (Seahorse Bioscience) was used for all XF assays. For experiments in which EVs were pre-exposed to the uncoupling agent FCCP, EVs were isolated as previously described. After the ultracentrifugation step at 100,000 x g for 70 min at 4°C, EVs were resuspended in 1 ml of Mφ medium with 1µM FCCP for 1 hr at 37 °C (EVs FCCP ), or Mφ medium alone (EVs). Particles were then washed with a centrifugation step at 100,000 x g for 30 min at 4°C, followed by resuspension in 200 µl of PBS and an additional wash with 3.2 ml of PBS.
Tubes were then subjected to an additional centrifugation at 100,000 x g for 30 min at 4°C using an optima MAX ultra with TLA110 fixed angle rotor, the supernatant was completely discarded and EVs FCCP (or EVs) were finally resuspended in Mφ medium at the desired concentration.
After the completion of each XF assay, cells were washed with PBS and 25 µl of 1X RIPA buffer (with protease/phosphatase inhibitors) were added to each well. The total protein amount/well was estimated with a BCA Protein Assay Kit (Thermo Scientific) and used to normalize the OCR and ECAR values of the single well.
Quantitative gene expression analysis (qPCR) and microarrays
Experiments in which EVs were pre-exposed to the uncoupling agent FCCP were performed as reported above.
For quantitative gene expression analysis (qPCR) total RNA was extracted using RNeasy kit 
Statistical analysis
Statistical analyses of all data were performed with Graph Pad Prism (version 8.00 for Mac, GraphPad Software). Differences among groups were analysed using One-Way-ANOVA followed by a Tukey's multiple comparison test (unless otherwise stated). Values are given in the text and figures as mean values ± SEM and a p value < 0.05 was accepted as significant in all analyses (unless otherwise stated).
Results
Proteomic analysis of NSC-derived EVs and exosomes identifies mitochondrial proteins
We first performed an untargeted multiplex Tandem Mass Tag (TMT)-based proteomic analysis of the whole EV fraction and sucrose-gradient purified exosomes spontaneously released by NSCs in vitro and compared them with parental NSC whole-cell lysates ( Fig. 1a and Table S1 ).
Using Gene Ontology Cellular Component (GOCC) annotations, we investigated the subcellular origin of proteins enriched in EVs compared with NSCs (Fig. 1b ). We found that proteins with annotations indicating exosomal localisation were markedly enriched in EVs, whereas proteins with annotations indicating nuclear localisation were depleted (Fig. 1c) . Interestingly, proteins with annotations indicating mitochondrial localisation were also significantly enriched in EVs vs NSCs ( Fig. 1b) .
To further investigate this finding, we next examined our data with more specific GOCC daughter annotations indicating localisation to the three major mitochondrial structural components: outer membrane, inner membrane and matrix. We found that proteins with these annotations were relatively enriched in EVs compared to parental NSCs (Fig. 1c ). We also specifically scrutinised the relative abundances of subunits of the five mitochondrial complexes and discovered that proteins coded in both the mitochondrial and nuclear genomes were all significantly enriched in EVs (Fig.   1d ). When we investigated specifically the DNA content of the EVs, we found that the mitochondrial gene NADH dehydrogenase subunit 1 (mt-ND1), which is encoded in the mtDNA, was present in EVs. However, this was not the case for the mitochondrial gene succinate dehydrogenase complex subunit D (Sdhd), which is encoded in the nuclear DNA ( Fig. 1e ), thus showing that nuclear DNA was not enriched but instead suggesting the likely presence of mitochondria with intact mitochondrial matrix in EVs.
To further validate our TMT-based proteomic data using an orthogonal technique, we next subjected EVs and NSCs to immunoblot analysis. EVs were enriched in exosomal markers (CD9, Pdcd6ip, Tsg101) and mitochondrial complexes, but depleted of Golgi markers (Golga2) (Fig. 1f) compared to NSCs. Conversely, a control preparation enriched of mitochondria (Mito) isolated from NSCs [15] was found to be depleted of CD9 and enriched in Golga2.
To exclude any potential bias related to our own purification methods, we further employed two additional high-quality and scalable exosome/EV isolation protocols that avoid ultracentrifugation [21, 29] (Fig. 2a ). We found that all protocols yielded EVs depleted of Golga2 but enriched in CD9 and mitochondrial proteins. In addition, we also tested another ultracentrifugation protocol that adds an additional 0.22 µm ultrafiltration step [68] and were able to readily detect mitochondrial complexes ( Fig. 2b) . Mitochondrial proteins are therefore found in NSC EVs, irrespective of the protocols used to isolate EVs from tissue culture media.
We next focused on the exosomal fraction isolated via sucrose gradient fractionation from the EV preparation, as described [9] . Compared with parental NSCs, the overall protein composition of exosomes by TMT-based proteomic analysis was similar to EVs (Table S1 ). However, we found that numerous proteins were selectively depleted in exosomes by the additional purification step compared to EVs (Fig. 3a) . Exosomes were also significantly enriched in proteins with GOCC annotations indicating localisation to the mitochondrial outer membrane, inner membrane, and matrix compared to parental NSCs (Fig. 3b ). Immunoblot analysis confirmed that fractions [6] [7] [8] [9] corresponding to the expected exosomal density were all enriched in mitochondrial complex proteins ( Fig. 3c) . When looking at the DNA content of the single fractions, we identified the mitochondrial gene mt-ND1 but not the Sdhd gene (Fig. 3d) , which unambiguously confirms that NSC exosomes, as well as EVs, harbour mitochondrial proteins and mtDNA.
Structurally and functionally intact mitochondria are found in NSCs derived EVs preparations
We next characterised the whole EV fraction released in vitro by NSCs using tunable resistive pulse sensing (TRPS) analysis and nanoparticle tracking analysis (NTA).
We found that EVs had a mode diameter ranging between 80 nm and 150.8 nm respectively, as described [9] (Fig. S1 ). This size distribution was then further investigated with a morphological analysis based on transmission electron microscopy (TEM). Amongst a heterogeneous population of EVs with a mode diameter of 286.7 nm, we identified several mitochondria-like structures, either free or encapsulated in other membranes, with a mean diameter of 695.4 nm (± 68.47 nm) ( Fig. 4a ).
We next used cryo-transmission electron microscopy (Cryo-TEM) [2] combined with immunogold labelling using an anti-TOMM20 antibody conjugated to gold nanoparticles to further confirm this finding. TOMM20 positive mitochondria were found in all EV preparations (Fig. 4b ). Altogether these complementary approaches suggest that in vitro NSCs spontaneously release EVs in the submicron range (<1000 nm) that include structurally intact mitochondria (Mito-EVs).
We then tested the functionality of these Mito-EVs by analysing the activity of the electron transport chain (ETC) in maintaining a mitochondrial transmembrane potential and respiration, using a JC1 assay and high resolution respirometry (HRR) [42], respectively. EVs indeed showed a conserved mitochondrial membrane potential, which was responsive to the mitochondrial uncoupler carbonyl cyanide m-chlorophenyl hydrazone (CCCP) (Fig. 4c ). In addition, EVs exhibited oxygen consumption when the substrates for the mitochondrial complexes were added to the EV preparation ( Fig. 4d,e ). When we tested the activity of the mitochondrial respiratory chain complexes, using blue native polyacrylamide gel electrophoresis (BN-PAGE) [47], intact protein complexes were isolated from EVs in native conditions (Fig. 4f ). This finding was coupled with a conserved catalytic activity of CI-CII-CIV, which suggests the presence of functionally intact mitochondrial complexes (Fig. 4g ) [70] .
Altogether these findings demonstrate that Mito-EVs released by NSCs harbour a functional mitochondrial ETC and the potential for oxidative phosphorylation (OXPHOS).
Mito-EVs revert the auxotrophy of mtDNA deficient cells
We next investigated whether NSC Mito-EVs have any effect on target cells. To this end, we generated NSCs that constitutively express the mitochondrial Mito-DsRed fluorescent reporter (MitoDsRed + NSCs) to stably label Mito-EVs. We then used Mito-DsRed + NSCs to derive EVs (MitoDsRed + -EVs) and treat cells that had been depleted of mtDNA using extended low-dose ethidium-bromide treatment [62] (Fig. 5a ). These L929 Rho 0 have an auxotrophic growth and dependence on extracellular uridine, which satisfies their energy demand despite the inhibition of dihydroorotate dehydrogenase (DHODH) allowing for cell survival [14] .
In conditions of uridine deprivation, we found that L929 Rho 0 cells efficiently incorporated MitoDsRed + -EVs within 24 hrs from treatment compared to L929 Rho 0 cells treated with a preparation enriched of isolated mitochondria (MitoDsRed + -Mito) ( Fig. 5b) . At 5 days post treatment, while only a minority of untreated L929 Rho 0 cells survived uridine depletion, L929 Rho 0 cells treated with MitoDsRed + -EVs displayed a significantly higher survival (Fig. 5c ). Finally, at 16 days post treatment, we were able to sequence the mt-ND3 mitochondrial gene from L929 Rho 0 cells treated with MitoDsRed + -EVs (Fig. 5d ), which indicates the efficient integration of (exogenous) Mito-EVderived mtDNA in target cells and a correction of their intrinsic mitochondrial DNA dysfunction.
These results show that NSC Mito-EVs are incorporated by and restore the mitochondrial function of persistently mtDNA-depleted target cells.
Mito-EVs are integrated in the mitochondrial network of mononuclear phagocytes via endocytosis
Mitochondrial function and immune metabolism guide the activation of mononuclear phagocytes in response to inflammatory stimuli [51] . Our recent work suggests that exogenous NSC transplants have immunomodulatory functions and inhibit the activation of pro-inflammatory mononuclear phagocytes in response to endogenous metabolic signals in vivo [49] . As such, to gain further insights onto the role of EVs in the immunomodulatory effects of NSCs, we next investigated whether Mito-EVs are trafficked to mononuclear phagocytes and, in so doing, affect their function.
Bone marrow-derived macrophages (Mφ) were challenged with lipopolysaccharide (LPS) to generate reactive, pro-inflammatory macrophages (Mφ LPS ) and then treated with MitoDsRed + -EVs ( Fig. 6a ). At 6 hrs after MitoDsRed + -EVs treatment, 67.47% (± 0.77) of the Mφ LPS showed intracellular MitoDsRed + intensity via FACS analysis, which was significantly higher than resting Mφ ( Fig. 6b ). Co-localisation analysis with confocal high-resolution spinning disk imaging allowed us to further investigate the intracellular fate of the incorporated Mito-EVs. We found that 6.58% (± 2.00) and 10.14% (± 2.85) of Mito-DsRed + Mito-EVs co-localized with either the lysosomal (LAMP1) or the peroxisomal (PMP70) markers ( Fig. 6c ), which suggests limited trafficking of Mito-EVs to these cellular compartments. Instead, 48.24% (± 4.43) and 17.75% (± 3.56) of Mito-DsRed + mitochondria were found either attached or included within the host Mφ LPS mitochondrial network ( Fig. 6d and Video S1). These data show that the majority of Mito-EVs preferentially escape the lysosomal and peroxisomal pathways, while instead co-localizing with the mitochondrial network of proinflammatory mononuclear phagocytes.
To further investigate the mechanism of Mito-EV incorporation into the host mitochondrial network of Mφ, we next analysed MitoDsRed + -EV incorporation in target Mφ LPS pre-treated with either the actin-mediated phagocytosis/endocytosis inhibitor cytochalasin D (Cyto) [33, 36] or the dynamin and clathrin-mediated endocytosis inhibitors Dynasore and Pitstop 2 (D/P) [12, 41] (Fig.   7a ). We found that Mφ LPS showed a significantly enhanced incorporation of MitoDsRed + -EVs as early as 15 min after exposure (Fig. 7b,c) . This effect was almost completely inhibited by the pre-treatment of Mφ LPS with (D/P), suggesting that Mito-EVs are predominantly incorporated via endocytosis to be later trafficked to the host mitochondrial network.
Mito-EVs change the mitochondrial dynamics, gene expression and metabolic profile of proinflammatory mononuclear phagocytes
During inflammation, Mφ undergo major changes in their function and metabolism, which are associated with modifications of their mitochondrial network dynamics [34, 67] . As such, we next investigated the structure of the mitochondrial network of pro-inflammatory Mφ after EV treatment.
We found that, while the stimulation with LPS promoted mitochondrial fission, the uptake of Mito-EVs and their integration into the host mitochondrial network led to a significant increase in fused mitochondria, as early as at 6 hrs after treatment (Fig. 8a) .
To understand the relevance of these structural changes and their functional consequences in a broader context, we analysed the gene expression profiles of Mφ LPS treated with EVs using RNA expression microarrays (Table S2 ). Generally Applicable Gene-set Enrichment (GAGE) analysis
[39] allowed us to identify specific Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways upregulated in Mφ LPS treated with Mito-EVs. Pathways related to ribosomes (mmu03010, q-value <0.01), carbon metabolism (mmu01200, q-value = 0.04), oxidative phosphorylation-OXPHOS (mmu00190, q-value = 0.04), antigen processing and presentation (mmu04612, q-value = 0.04) and phagosomes (mmu04145, q-value = 0.04) were all upregulated in Mφ LPS treated with EVs (Fig. 8b ).
Interestingly, among the genes differentially expressed in the OXPHOS pathway, several genes encoding for the different subunits of the ETC were upregulated in Mφ LPS after EV treatment, as shown by the Pathview diagram [38] (Fig. S2 ), suggesting a putative increase of cellular respiration.
As such, we next measured the oxygen consumption rate (OCR) of Mφ LPS after EVs treatment, and found that the basal OCR, as well as the maximum respiratory capacity was increased in Mφ LPS after EV treatment (Fig. 8c ). These findings are in line with an increase in maximal respiration rate as an index of metabolic activity associated with fused mitochondrial networks [58] and they show that Mito-EVs can revert the transient mitochondrial dysfunction associated with the proinflammatory state of Mφ.
To prove that functional mitochondria trafficked within EVs were indeed responsible for the abovementioned changes, we treated Mφ LPS with EVs that had been pre-exposed to the mitochondrial un-coupler carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP), EV FCCP .
While treatment with control EVs rescued the changes in the OCR and extracellular acidification rate (ECAR) induced by LPS in Mφ, treatment with EV FCCP failed to do so (Fig. 8d) . Moreover, control
EVs, but not EV FCCP , succeeded in downregulating the expression of the LPS-induced proinflammatory cytokine genes Il1b, Il6 and Nos2 (Fig. 8e) in Mφ LPS .
Overall these data show that NSC Mito-EVs integrate into the transiently dysfunctional host mitochondrial network of pro-inflammatory Mφ, where they re-establish physiological mitochondrial dynamics, cellular metabolism and inflammatory gene profiles.
Transplanted NSCs transfer mitochondria to host cells in vivo during EAE.
Previous evidence has suggested that mitochondrial transfer occurs in vivo and may be involved in diverse pathophysiological situations, including tissue injury and cancer progression [63] .
Therefore, in order to determine if our in vitro findings had any functional relevance in vivo, NSCs or EVs were injected intracerebroventricularly (ICV) at the peak of disease (PD) into mice with MOG 35-55 -induced chronic experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis.
To reliably detect NSCs and EVs in vivo, NSCs were previously labelled in vitro with both the Mito-DsRed fluorescent reporter and farnesylated (f)GFP to generate fGFP + /MitoDsRed + NSCs. EVs spontaneously released by fGFP + /MitoDsRed + NSCs in vitro were then collected and used for in vivo studies (Fig. 9a ).
In line with published results, a single ICV injection of NSCs resulted in a significant amelioration of EAE disease severity (from 44 days post immunisation, dpi, onwards) when compared to PBSinjected EAE mice [54] . Likewise, we found that a single ICV injection of EVs was able to significantly ameliorate EAE disability in mice (starting from 50 dpi) compared to PBS-injected EAE mice (Fig.   9b ).
Following the end of the clinical observation period (55 dpi To determine the target cell(s) of these mitochondrial transfer events, we next quantified the number of fGFP -/MitoDsRed + mitochondria within the three major CNS cell types (astrocytes, neurons and oligodendrocytes) and the immune cells that comprise most of the EAE inflammatory lesions (T cells and mononuclear phagocytes) ( Fig. 9c ). Our analysis revealed that the majority of fGFP -/MitoDsRed + mitochondria were incorporated into mononuclear phagocytes F4/80 + (~50%) and, to a lesser extent, GFAP + astrocytes (~35%). A minor fraction of fGFP -/MitoDsRed + mitochondria (~15%) was distributed between NeuN + neurons, Olig2 + oligodendrocytes, or CD3 + T cells (Fig. 9d) .
These results show that mitochondrial transfer from NSCs happens in vivo and that in conditions of neuroinflammation it is predominantly directed towards mononuclear phagocytes and host astrocytes.
Discussion
Extracellular release of mitochondria and horizontal mitochondria transfer between cells are reported in several cells and organs, including the CNS [20, 53] . However, the relevance and the biological function of these phenomena are still a matter of debate.
On one hand, cells can release dysfunctional mitochondria for recycling and disposal [10, 52] .
Mitoptosis -the selective elimination of malfunctioning mitochondria -is described in cells under conditions of severe mitochondrial stress where the occlusion of mitochondrial clusters by a membrane ("mitoptotic body") allows its protrusion from the cell [40] . Similarly, transmitophagy -a process of transcellular degradation of damaged mitochondria through horizontal transfer -is observed between neurons and astrocytes [10] and between mesenchymal stem cells (MSCs) and macrophages [52] . In addition, it has been shown that during oxidative stress, mitochondria produce their own mitochondria-derived vesicles (MDVs) that are trafficked intracellularly either to peroxisomes [46] or to multivesicular bodies and the exosomal pathway [59] . Overall, the effect of these mechanisms is to enhance the survival of the donor cell via disposal of dysfunctional mitochondria, by routes that include unloading into neighbouring cells.
On the other hand, cells can also release intact mitochondria which retain functional properties [19, 20, 53, 56, 57, 60] . The transfer of healthy mitochondria has been demonstrated in different tissues and organs, where its main role is to maintain local homeostasis. In the CNS, astrocytes provide healthy mitochondria to damaged neurons to restore normal OXPHOS both in vitro and in vivo [20, 53] . Similarly, endothelial progenitor cells support brain endothelial energetics and barrier integrity through extracellular mitochondrial transfer [19] . Herein, we first investigated the protein content of EVs that are spontaneously released by NSCs.
We found that EVs were enriched in mitochondrial proteins of the outer membrane, matrix, inner membrane and ETC, while morphological analysis confirmed the presence of entire mitochondria, as previously shown in other cellular systems [4, 6, 7] . Most importantly, we demonstrate that mitochondria spontaneously released by NSCs within EVs (Mito-EVs) have intact complexes, active complex activity, and conserved mitochondrial membrane potential and respiration. Altogether these data show that NSCs release mitochondria into the extracellular space, wherein they still harbour functional properties that can be transferred to target cells.
Unravelling the physiological significance of the mitochondrial transfer via EVs required the development of novel fluorescence and genetic mitochondrial tracking tools. To this aim, we generated NSCs lines stably expressing the MitoDsRed protein, which allowed for the expression of the fluorescent reporter in Mito-EVs. Thanks to this approach, we first provided evidence of functional mitochondria transfer from NSCs to L929 Rho 0 cells, where Mito-EVs succeeded in reverting their intrinsic mitochondrial dysfunction and auxothropy.
Mitochondria transfer is emerging as a novel mechanism regulating the activity of the immune system. Besides the well described release of mitochondria from immune cells such as monocytes [4, 55] , other immune regulatory cells modulate the activity of inflammatory cells via horizontal mitochondrial transfer [23] . As such, we next questioned whether Mito-EVs could also exert any regulatory functions on mononuclear phagocytes (Mφ) that display a transient dysfunction of mitochondria secondary to LPS stimulation.
Key to these investigations was to reveal how extracellular mitochondria enter into Mφ, which is an important step for the future development of treatment strategies designed to transfer healthy mitochondria from stem cells into immune cells. Our experiments showed that Mφ treated with EVs incorporated exogenous mitochondria preferentially via clathrin or dynamin mediated endocytosis. This is in line with previous reports showing that mitochondrial transfer events from MSCs to target NSCs showed exogenous mitochondria being exchanged between the graft and host cells, suggesting a continuous production and release of mitochondria by NSCs in vivo. Of note, the majority of the mitochondrial transfer events was observed between NSCs and mononuclear phagocytes, strengthening the relevance of our in vitro findings and suggesting that similar immunoregulatory effects may be relevant also in vivo. Finally, a single ICV injection of EVs induced a significant amelioration of clinical deficits in EAE mice suggesting that acellular approaches, similar to NSCs grafts, may be beneficial for the treatment of neuroinflammatory disorders.
Overall, our work provides convincing proof-of-evidence that functional mitochondrial horizontal transfer occurs NSCs, paving the way for future investigations aiming at discovering the intracellular signals that link upstream mitochondrial release to downstream regulation of target cell phenotype and function. Moreover, we also support the hypothesis that NSCs mitochondrial horizontal transfer is indeed a mechanism of cell-to-cell signalling that can contribute to the immune-modulation of Mφ [69] . Future therapeutic implications of this research will need to consider strategies to pharmacologically enhance intercellular organelle transfer when desirable, such as in neuroinflammation [43, 50, 51] ; or block its occurrence when it is deleterious [13] .
Nonetheless, we are also fully aware of the main limitations of our work. As such, the need for a reassessment of exosome composition and a better framework for the distinction of EVs and non-vesicular fractions is still needed.
Indeed, a second caveat of our study is the unknown nature of the NSC mitochondrial release mechanism. The release of mitochondria seems to be correlated with the metabolic state of the donor cell, as the same cell derived from different tissue sources has different mitochondrial donor properties, which are correlated with its respiratory state [48] . Cells with high mitochondrial respiration capacities are indeed associated with lower mitochondrial transfer. This is compatible with a model where donor cells optimally regulate mitochondrial transfer such that they transfer more mitochondria if they depend less on their function. Interestingly, NSCs are known to be highly glycolytic cells, which rely on glycolysis rather than OXPHOS for energy production [11] . As such, it is tempting to speculate that NSCs might have increased mitochondrial donor properties compared to other cell types, and that specific stimuli affecting their metabolism might further enhance this mechanism.
In conclusion, our work provides new insights to the contribution of mitochondria to the content and biological activity of EVs released by NSCs, suggesting that EV-mediated paracrine actions and mitochondrial transfer are two independent, but possibly interactive, pathways that allow their Fig. 1a . A total of 187 proteins were found to be significantly depleted in exosomes, vs EVs (blue), while 25 proteins were significantly enriched (red); q < 0.05 (Table S1) Complete dataset (unfiltered) from multiplex TMT-based proteomic experiment illustrated in Fig 1a. Normalised, unscaled protein abundances (biological replicates 1-3), log 2 (ratios), q values and the numbers of unique peptides used for protein quantitation are shown. NSC, NSC whole cell lysates;
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EV, whole EV fraction; Exo, sucrose-gradient purified exosomes. 
